Kosinska AD - Search Results

1

Activation of CD4 T cells during prime immunization determines the success of a therapeutic hepatitis B vaccine in HBV-carrier mouse models.

Su J, Brunner L, Ates Oz E, Sacherl J, Frank G, Kerth HA, Thiele F, Wiegand M, Mogler C, Aguilar JC, Knolle PA, Collin N, Kosinska AD, Protzer U. Su J, et al. Among authors: kosinska ad. J Hepatol. 2023 Apr;78(4):717-730. doi: 10.1016/j.jhep.2022.12.013. Epub 2023 Jan 9. J Hepatol. 2023. PMID: 36634821 Free article.

2

Protein-prime/modified vaccinia virus Ankara vector-boost vaccination overcomes tolerance in high-antigenemic HBV-transgenic mice.

Backes S, Jäger C, Dembek CJ, Kosinska AD, Bauer T, Stephan AS, Dišlers A, Mutwiri G, Busch DH, Babiuk LA, Gasteiger G, Protzer U. Backes S, et al. Among authors: kosinska ad. Vaccine. 2016 Feb 10;34(7):923-32. doi: 10.1016/j.vaccine.2015.12.060. Epub 2016 Jan 15. Vaccine. 2016. PMID: 26776470

3

Therapeutic vaccination for chronic hepatitis B.

Kosinska AD, Bauer T, Protzer U. Kosinska AD, et al. Curr Opin Virol. 2017 Apr;23:75-81. doi: 10.1016/j.coviro.2017.03.011. Epub 2017 Apr 25. Curr Opin Virol. 2017. PMID: 28453967 Review.

4

Amino Acid Substitutions within HLA-B*27-Restricted T Cell Epitopes Prevent Recognition by Hepatitis Delta Virus-Specific CD8⁺ T Cells.

Karimzadeh H, Kiraithe MM, Kosinska AD, Glaser M, Fiedler M, Oberhardt V, Salimi Alizei E, Hofmann M, Mok JY, Nguyen M, van Esch WJE, Budeus B, Grabowski J, Homs M, Olivero A, Keyvani H, Rodríguez-Frías F, Tabernero D, Buti M, Heinold A, Alavian SM, Bauer T, Schulze Zur Wiesch J, Raziorrouh B, Hoffmann D, Smedile A, Rizzetto M, Wedemeyer H, Timm J, Antes I, Neumann-Haefelin C, Protzer U, Roggendorf M. Karimzadeh H, et al. Among authors: kosinska ad. J Virol. 2018 Jun 13;92(13):e01891-17. doi: 10.1128/JVI.01891-17. Print 2018 Jul 1. J Virol. 2018. PMID: 29669837 Free PMC article.

5

Synergy of therapeutic heterologous prime-boost hepatitis B vaccination with CpG-application to improve immune control of persistent HBV infection.

Kosinska AD, Moeed A, Kallin N, Festag J, Su J, Steiger K, Michel ML, Protzer U, Knolle PA. Kosinska AD, et al. Sci Rep. 2019 Jul 25;9(1):10808. doi: 10.1038/s41598-019-47149-w. Sci Rep. 2019. PMID: 31346211 Free PMC article.

6

Dynamic, Helminth-Induced Immune Modulation Influences the Outcome of Acute and Chronic Hepatitis B Virus Infection.

Loffredo-Verde E, Bhattacharjee S, Malo A, Festag J, Kosinska AD, Ringelhan M, Rim Sarkar S, Steiger K, Heikenwaelder M, Protzer U, Prazeres da Costa CU. Loffredo-Verde E, et al. Among authors: kosinska ad. J Infect Dis. 2020 Apr 7;221(9):1448-1461. doi: 10.1093/infdis/jiz594. J Infect Dis. 2020. PMID: 31875228

7

Knockdown of Virus Antigen Expression Increases Therapeutic Vaccine Efficacy in High-Titer Hepatitis B Virus Carrier Mice.

Michler T, Kosinska AD, Festag J, Bunse T, Su J, Ringelhan M, Imhof H, Grimm D, Steiger K, Mogler C, Heikenwalder M, Michel ML, Guzman CA, Milstein S, Sepp-Lorenzino L, Knolle P, Protzer U. Michler T, et al. Among authors: kosinska ad. Gastroenterology. 2020 May;158(6):1762-1775.e9. doi: 10.1053/j.gastro.2020.01.032. Epub 2020 Jan 28. Gastroenterology. 2020. PMID: 32001321

8

Fetomaternal immune cross talk modifies T-cell priming through sustained changes to DC function.

Lacorcia M, Bhattacharjee S, Laubhahn K, Alhamdan F, Ram M, Muschaweckh A, Potaczek DP, Kosinska A, Garn H, Protzer U, Renz H, Prazeres da Costa C. Lacorcia M, et al. J Allergy Clin Immunol. 2021 Sep;148(3):843-857.e6. doi: 10.1016/j.jaci.2021.02.031. Epub 2021 Mar 5. J Allergy Clin Immunol. 2021. PMID: 33684437

9

Intramolecular recombination enables the formation of hepatitis B virus (HBV) cccDNA in mice after HBV genome transfer using recombinant AAV vectors.

Ko C, Su J, Festag J, Bester R, Kosinska AD, Protzer U. Ko C, et al. Among authors: kosinska ad. Antiviral Res. 2021 Oct;194:105140. doi: 10.1016/j.antiviral.2021.105140. Epub 2021 Jul 17. Antiviral Res. 2021. PMID: 34284057

10

Immunogenicity and Antiviral Response of Therapeutic Hepatitis B Vaccination in a Mouse Model of HBeAg-Negative, Persistent HBV Infection.

Kosinska AD, Festag J, Mück-Häusl M, Festag MM, Asen T, Protzer U. Kosinska AD, et al. Vaccines (Basel). 2021 Jul 31;9(8):841. doi: 10.3390/vaccines9080841. Vaccines (Basel). 2021. PMID: 34451966 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

34 results

Search Page